NCT02533492

Brief Summary

Total knee replacement is now one of the most popular reconstructive procedures for the elderly people to regain their functional capacity and life quality. However the reported incidence of postoperative infection or surgical site infection after total knee replacement has been around 1 to 2 percent. The cost and expenditure for treating periprosthetic infection are high and the results are often detrimental to the patients who suffered from the complication. To decrease the wound healing complication related to the contamination of bacteria, an antibacterial suture was used successfully in some clinical settings and in animal experiments. Whether the antibacterial suture material could be used in patients with total knee replacement has not been addressed in the past. The investigators therefore propose a prospective randomized double-blinded study to investigate the efficacy of an antibacterial suture material in total knee replacement. The inclusion criteria are patients with degenerative osteoarthritis without previous surgery to the index knee. Patients who have inflammatory arthritis such as rheumatoid arthritis, who have neurovascular disease of the lower extremities, who have history of liver cirrhosis or under hemodialysis for renal failure are excluded. One hundred and two patients will be randomized to study group (51 knees) and control group (51 knees) in a period of 12 months. All cases will follow the standard protocol based on clinical pathway. Antibacterial suture material (Vicryl Plus, Ethicon) will be used in the study group and regular suture material (Vicryl, Ethicon) will be used in the control group. Preoperatively, the skin condition (digital photo and image analysis),laser Doppler study, inflammatory markers (CRP/ESR/IL-6), functional score (KSS: Knee Society Score; SF-12: Short Form 12), and VAS score will be assessed. Operative data of operation time, blood loss and wound classification are recorded. Postoperatively, the skin condition (digital photo and image analysis), skin temperature, inflammatory markers, KSS, and VAS will be assessed on 1st and 3rd postoperative day, 2 weeks, 4 weeks, and 3 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Jun 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

August 20, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 26, 2015

Completed
Last Updated

August 26, 2015

Status Verified

August 1, 2015

Enrollment Period

1.5 years

First QC Date

August 20, 2015

Last Update Submit

August 24, 2015

Conditions

Keywords

total knee replacementvicryl plussurgical site infection

Outcome Measures

Primary Outcomes (1)

  • wound infection

    3 months

Secondary Outcomes (1)

  • serum inflammatory marker

    3 months

Other Outcomes (1)

  • Physiological parameter (skin temperature)

    3 months

Study Arms (2)

Vicryl

ACTIVE COMPARATOR

Vicryl suture for wound closure after total knee replacement

Device: vicryl

vicryl plus

EXPERIMENTAL

Vicryl plus suture for wound closure after total knee replacement

Device: Vicryl plus

Interventions

vicrylDEVICE

wound closure with vicryl suture

Also known as: polyglactin
Vicryl

wound closure with vicryl plus suture

Also known as: triclosan-coated polyglactin
vicryl plus

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Degenerative osteoarthritis
  • Any age
  • Varus/valgus deformity knee

You may not qualify if:

  • Inflammatory arthritis
  • Systemic diseases with coagulopathy
  • Immune compromise(ESRD, liver cirrhosis)
  • PAOD or DVT history
  • Pre-OP INR \>1.5
  • ASA score \>3

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Kweishan, Taoyuan, 333, Taiwan

Location

Related Publications (2)

  • Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008 Aug;2(2):111-7. doi: 10.3171/PED/2008/2/8/111.

    PMID: 18671615BACKGROUND
  • Lin SJ, Chang FC, Huang TW, Peng KT, Shih HN, Lee MS. Temporal Change of Interleukin-6, C-Reactive Protein, and Skin Temperature after Total Knee Arthroplasty Using Triclosan-Coated Sutures. Biomed Res Int. 2018 Jan 15;2018:9136208. doi: 10.1155/2018/9136208. eCollection 2018.

MeSH Terms

Conditions

Wound InfectionSurgical Wound Infection

Condition Hierarchy (Ancestors)

InfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chang Gung Memorial Hospital, Dept Orthopedic Surgery

Study Record Dates

First Submitted

August 20, 2015

First Posted

August 26, 2015

Study Start

June 1, 2011

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

August 26, 2015

Record last verified: 2015-08

Locations